慢性阻塞性肺病患者诊断治疗标准(Standards for the diagnosis and treatment of patients with COPD).pptVIP

ERS-ATS COPD Guidelines Copyright ? European Respiratory Society 2005 These slides can be used freely for non-commercial purposes. Document authors Document Goals and Objectives (1) The Standards for the Diagnosis and Treatment of Patients with COPD document updates the position papers on COPD published by the ATS and the ERS in 1995. Both organisations acknowledge the recent dissemination of the Global Initiative of Obstructive Lung Disease (GOLD) as a major contribution against COPD. However, an adaptation of GOLD was deemed necessary to match specific requirements of the members of both societies. Those requirements include specific recommendations on oxygen therapy, pulmonary rehabilitation, noninvasive ventilation, surgery in and for COPD, sleep, air travel, and end-of-life. Document Goals and Objectives (2) These guidelines aim at: Improving the quality of care provided to patients with COPD. Promoting the use of a disease-oriented approach. Maintaining a synchronous flow with the wider objectives of GOLD. Using an electronic, web-based format which can be updated any time a modification is deemed necessary. Definition of COPD Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease state characterised by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking. Epidemiology (1) COPD is a leading cause of morbidity and mortality worldwide, and results in an economic and social burden that is both substantial and increasing. Prevalence and morbidity data greatly underestimate the total burden of COPD because the disease is usually not diagnosed until it is clinically apparent and moderately advanced. Epidemiology (2) COPD is the fourth leading cause of death in the USA and Europe, and COPD mortality in females has more than doubled over the last 20 years. Epid